Young Women Face Near-Zero Risk of Cervical Cancer Death After HPV Vaccine, Study Finds
What if a vaccine given at age 12 could almost eliminate deaths from cervical cancer before age 30? According to a landmark UK study, that possibility is becoming reality. Researchers found that young women who received the HPV vaccine during their early teens now have a close to zero risk of dying from cervical cancer before the age of 30.
The findings mark a major milestone in cancer prevention. Experts say the results provide powerful evidence that the HPV vaccine saves lives and could eventually help eliminate cervical cancer as a public health problem.
The HPV Vaccine Is Preventing Cervical Cancer Deaths
A study published in The Lancet and led by researchers at Queen Mary University of London examined cervical cancer deaths in England. The research, funded by Cancer Research UK, found dramatic declines in deaths since the HPV vaccine was introduced for girls aged 12 and 13 in 2008.
Between 2020 and 2024, there were no recorded cervical cancer deaths among women aged 20 to 24 in England. Researchers estimated that around 23 deaths would have been expected without vaccination.
The study also found:
- An 80% reduction in cervical cancer deaths among women aged 20 to 24 between 2015 and 2019.
- Nearly 200 deaths prevented through HPV vaccination in England by the end of 2024.
- A 100% reduction in the risk of death from cervical cancer among vaccinated women under 30.
- A 63% reduction in mortality among women aged 30 to 34.
These findings represent the first time researchers have directly shown that the HPV vaccine is saving lives.
Why the HPV Vaccine Is So Effective
Human papillomavirus (HPV) is a group of viruses spread mainly through sexual contact. Around 13 high-risk HPV types are responsible for nearly all cervical cancer cases.
Most HPV infections clear naturally. However, some infections can cause abnormal cell changes that develop into cancer years later.
The vaccine works best when given before exposure to the virus. That is why health authorities recommend vaccination for children around ages 12 and 13.
Vaccination at a Younger Age Provides Greater Protection
Researchers noted that women aged 30 to 34 received lower levels of protection because many were vaccinated later, between ages 15 and 18. By that time, some may have already been exposed to HPV strains 16 and 18.
Consequently, the vaccine was less effective for that age group compared with those vaccinated earlier.
Experts Call Results an Important Milestone
Professor Peter Sasieni, lead researcher at Queen Mary University of London, said the results show that the HPV vaccine works on a population scale.
He explained that before vaccination programs, there had never been a year without cervical cancer deaths among young women.
He also described the current results as “the tip of the iceberg.” According to him, the full benefits will become clearer as vaccinated generations age.
Meanwhile, Cancer Research UK called the findings an “incredible milestone.”
Michelle Mitchell, the charity’s chief executive, said the study proves the vaccine stops cervical cancer before it starts and is now clearly saving lives.
Falling Vaccination Rates Raise Concerns
Despite the encouraging results, experts remain worried about declining vaccine uptake.
Before the COVID-19 pandemic, HPV vaccine coverage in England reached between 80% and 90%. However, more recent figures show a decline.
By 2024-25:
- About 76% of girls in England had received the vaccine by age 15.
- In London, coverage dropped to around 61%.
- Some local areas reported vaccination rates below 50%.
Professor Sasieni warned that lower uptake could lead to a resurgence of cervical cancer among young women.
Therefore, health experts are urging families to ensure eligible children receive the vaccine.
Ireland Continues Efforts to Improve HPV Vaccination
Ireland introduced the HPV vaccine for girls in 2010 and expanded it to boys in 2019.
However, vaccination rates declined sharply after 2015. According to the latest available data, overall vaccine uptake among first-year secondary school students during the 2023-2024 academic year stood at 74.9%.
The World Health Organization has set a target of 90% vaccine coverage. Ireland aims to meet that goal and eliminate cervical cancer by 2040.
The Laura Brennan Catch-Up Campaign
Laura Brennan became a leading advocate for HPV vaccination after being diagnosed with cervical cancer. She died at the age of 24.
To honor her legacy, Ireland launched a catch-up vaccination campaign in her name.
Initially offered to fifth and sixth-year students, the program will expand to include second through fifth-year students during the upcoming academic year.
Her brother, Kevin Brennan, said Laura would have been thrilled by the latest findings because she always believed the vaccine saves lives.
A Survivor Shares Why Vaccination Matters
Alexandra Legg missed receiving the HPV vaccine because she left school before the program began in England.
At age 30, while planning her wedding, she received a cervical cancer diagnosis.
Her treatment included surgery and the removal of lymph nodes. Fortunately, doctors preserved part of her cervix, allowing her to become pregnant later.
She gave birth to her daughter Ivy, whose middle name, Marvella, means “miracle.”
Today, Alexandra strongly supports vaccination and says her daughter will be among the first to receive the HPV vaccine when eligible.
HPV Vaccine Also Protects Against Other Cancers
The benefits of HPV vaccination extend beyond cervical cancer.
The vaccine can also help prevent:
- Head and neck cancers
- Mouth cancers
- Throat cancers
- Anal cancer
- Penile cancer
- Genital warts
Additionally, vaccinating boys helps reduce virus transmission and protects both sexes from HPV-related diseases.
Global Goal: Eliminate Cervical Cancer
In 2020, the World Health Organization launched its strategy to eliminate cervical cancer as a public health problem.
The WHO’s “90-70-90” targets aim to ensure:
| Goal | Target |
| Girls vaccinated by age 15 | 90% |
| Women screened by age 35 and 45 | 70% |
| Women with cervical disease treated | 90% |
The UK government and Ireland have both committed to eliminating cervical cancer by 2040.
Meanwhile, health officials continue promoting screening programs because regular cervical screening remains important even for vaccinated women.
Conclusion
The latest research offers some of the strongest evidence yet that the HPV vaccine is transforming women’s health. For girls vaccinated at ages 12 and 13, the risk of dying from cervical cancer before age 30 has become almost zero.
Furthermore, nearly 200 lives have already been saved in England. Experts believe many more deaths will be prevented as vaccinated generations grow older.
However, maintaining high vaccination rates remains essential. As health authorities push toward eliminating cervical cancer, the message from researchers and survivors is clear: vaccination saves lives.
FAQs
1. How effective is the HPV vaccine against cervical cancer?
Research shows the HPV vaccine reduces the risk of cervical cancer death by 100% in vaccinated women under age 30.
2. At what age should children receive the HPV vaccine?
Health authorities recommend vaccination around ages 12 to 13, before exposure to HPV.
3. Does the HPV vaccine protect boys too?
Yes. Boys benefit from protection against anal, penile, throat, and mouth cancers and help reduce virus transmission.
4. Is cervical screening still necessary after vaccination?
Yes. Women aged 25 to 64 are still advised to attend regular cervical screening appointments.
5. Can HPV cause other cancers besides cervical cancer?
Yes. HPV is linked to several cancers, including mouth, throat, anal, and penile cancers.
